MP Bio COVID-19 IgG/IgM Rapid Test

MP Bio COVID-19 IgG/IgM Rapid Test

£0.00

Designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma or whole blood. MP Rapid 2019-nCoVIgG/IgM Combo Test Card is an immunochromatography based one-step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV,SARS-CoV-2) in human serum, plasma, or whole blood. MP Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplementary detection for COVID-19 infected suspected individuals besides nucleic acid testing, which could greatly raise the accuracy of the detection for COVID-19. This product is CE-IVD marked for professional use and complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC).

Learn More

Add To Cart
Homepage > Products > SARS-CoV-2 > MP Bio COVID-19 IgG IgM Rapid Test

Features

Features and Benefits
  • Simpler sampling - Only 2 μL of serum, plasma or whole blood is needed
  • Excellent performance: Specificity 99.03%, Sensitivity 96.39%, Accuracy 98.59%.
  • No equipment required to operate. Test can be conducted on any site.
  • 10 minute rapid result time
  • Convenient package for easy distribution
  • 18 month storage life at room temperature
  • Optimised detection - can detect specific antibodies to both N and S virus proteins for improved
Remote Training

We have a team of trainers who are registered nurses ready to provide training sessions over Microsoft Teams and Zoom. We also have videos and laminated wall mount Quick Guides to support your training requirements.

Kit Contents

Kit Contents
  • 25 x MP Rapid Tests
  • 26 x Pipettes
  • 1 x Sample Buffer
  • 1 x Instructions for Use

Specifications

Full Specifications


SKU 07RDCOV19
Analyte / Target IgG and IgM antibodies to COVID-19
Base Catalog Number RDCOV19
Components Rapid 2019-nCov IgG/IgM Combo Test Card x 25, sample buffer, capillary pipettes and instructions for use.
Disease Screened Coronavirus disease 2019 (COVID-19)
Pack Size 25 Tests
Sample Type Plasma, Serum, Whole Blood
Sample Volume 2 uL
Sensitivity 94.74%
Species Reactivity Human
Specificity 97.06%
Usage Statement This product is CE-IVD marked for professional use and complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC). Not for sale in the USA.

This product is CE-IVD marked for professional use and complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC).

Downloads and Helpful Links

Get in touch

Name